These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 17212315)
1. [The Medical Products Agency's new guidelines for primary prevention of cardiovascular diseases. No help to physicians]. Berglund G Lakartidningen; 2006 Nov 22-28; 103(47):3694-5. PubMed ID: 17212315 [No Abstract] [Full Text] [Related]
2. [Reply concerning the new Medical Products Agency's guidelines for primary prevention of cardiovascular diseases. Issuing recommendations based on available evidence basis an ethical duty]. Beermann B Lakartidningen; 2006 Nov 22-28; 103(47):3731-2. PubMed ID: 17212324 [No Abstract] [Full Text] [Related]
3. [Polish forum for prevention guidelines on cardiovascular risk assessment]. Podolec P; Kopeć G; Pajak A; Undas A; Kozek E; Tykarski A; Naruszewicz M; Stańczyk J; Opala G; Godycki-Cwirko M; Rynkiewicz A; Torbicki A; Musiał J Kardiol Pol; 2007 Jan; 65(1):100-4. PubMed ID: 17295170 [No Abstract] [Full Text] [Related]
4. The prevention of cardiovascular disease: have we really made progress? Pearson TA Health Aff (Millwood); 2007; 26(1):49-60. PubMed ID: 17211013 [TBL] [Abstract][Full Text] [Related]
5. The heart of the matter: reducing CVD risk. Hayman LL; Kamau MW; Stuart-Shor EM Nurse Pract; 2009 May; 34(5):30-5. PubMed ID: 19390396 [No Abstract] [Full Text] [Related]
10. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events. Dennison CR; Hughes S J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796 [No Abstract] [Full Text] [Related]
11. Guidelines update on the prevention of heart disease in women. Caboral MF; King WV; Goolsby MJ J Am Acad Nurse Pract; 2008 Apr; 20(4):191-3. PubMed ID: 18387015 [No Abstract] [Full Text] [Related]
12. [Time for a European perspective on cardiovascular prevention]. Nilsson PM; Perk J; Rydén L Lakartidningen; 2008 Apr 2-8; 105(14):1000-4. PubMed ID: 18478749 [No Abstract] [Full Text] [Related]
13. [Primary prevention of cardiovascular disease should be based on absolute risk assessment]. Nilsson PM Lakartidningen; 2005 Feb 14-20; 102(7):496-7. PubMed ID: 15768700 [No Abstract] [Full Text] [Related]
14. [Cardiovascular risk in inflammatory systemic disease should be assessed regularly. The Swedish Society of Rheumatology has formulated guidelines for primary prevention]. Jonsson SW; Ljung L; D'Elia HF; Henrohn D; Turesson C; Svenungsson E Lakartidningen; 2012 Jan 11-17; 109(1-2):27-9. PubMed ID: 22468407 [No Abstract] [Full Text] [Related]
15. [The Medical Products Agency's view on treatment of increased serum lipids]. Forslund L Lakartidningen; 2008 Nov 19-25; 105(47):3463. PubMed ID: 19112983 [No Abstract] [Full Text] [Related]
17. [The JUPITER study emphasizes primary prevention]. Olsson AG Lakartidningen; 2009 Jun 3-9; 106(23):1577. PubMed ID: 19583019 [No Abstract] [Full Text] [Related]
18. [A new European concept for prevention of cardiovascular diseases]. Orth-Gomér K Lakartidningen; 2004 May; 101(20):1774-5. PubMed ID: 15190765 [No Abstract] [Full Text] [Related]
19. [Presentation: European practice guidelines for the prevention of cardiovascular diseases in clinical practice]. Di Pasquale G G Ital Cardiol (Rome); 2008 Jan; 9(1):9-10. PubMed ID: 18383762 [No Abstract] [Full Text] [Related]